EP
ABMD

Elkfork Partners’s Abiomed Inc ABMD Stock Holding History

Elkfork Partners’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$540K Buy
3,036
+616
+25% +$133K 0.01% 551
2019
Q2 		$630K Buy
2,420
+132
+6% +$35K 0.02% 513
2019
Q1 		$653K Buy
2,288
+264
+13% +$87.7K 0.02% 490
2018
Q4 		$658K Sell
2,024
-176
-8% -$61.1K 0.02% 448
2018
Q3 		$989K Sell
2,200
-5,368
-71% -$2.12M 0.02% 381
2018
Q2 		$3.1M Buy
7,568
+946
+14% +$343K 0.08% 219
2018
Q1 		$1.93M Buy
6,622
+308
+5% +$78.1K 0.05% 240
2017
Q4 		$1.18M Buy
6,314
+2,134
+51% +$398K 0.03% 327
2017
Q3 		$705K Buy
4,180
+440
+12% +$66.5K 0.02% 403
2017
Q2 		$536K Buy
3,740
+1,540
+70% +$207K 0.02% 480
2017
Q1 		$276K Sell
2,200
-484
-18% -$56.1K 0.01% 546
2016
Q4 		$303K Buy
+2,684
New +$311K 0.01% 511

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Elkfork Partners's ABMD Position: Q3 2019 in Review

Elkfork Partners increased its Abiomed Inc (ABMD) stake by 25% in Q3 2019, buying an estimated $133K and bringing the position to 3,036 shares worth $540K. The position accounts for 0.01% of the portfolio, ranked #551.

Elkfork Partners first reported a position in ABMD in Q4 2016 and has held it in 12 quarters since. The position peaked at $3.1M in Q2 2018. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

  • Elkfork Partners held 3,036 shares of Abiomed Inc worth $540K as of Q3 2019.
  • Elkfork Partners bought 616 Abiomed Inc shares in Q3 2019, an estimated $133K.
  • Abiomed Inc made up 0.01% of Elkfork Partners's portfolio in Q3 2019, its #551 holding.
  • Elkfork Partners first reported a position in Abiomed Inc in Q4 2016 and has held it in 12 quarters since.
  • Elkfork Partners's Abiomed Inc position peaked at $3.1M in Q2 2018.
  • 443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.